Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 8 May 1992:
Vol. 256. no. 5058, pp. 774 - 779
DOI: 10.1126/science.1375392

Articles

Science, Vol 256, Issue 5058, 774-779
Copyright © 1992 by American Association for the Advancement of Science


articles

Cystic fibrosis: molecular biology and therapeutic implications

FS Collins

Department of Internal Medicine, University of Michigan, Ann Arbor 48109-0650.

Cystic fibrosis is the most common potentially lethal autosomal recessive disease of Caucasians, affecting 1 in 2500 newborns. Since the recent identification of the gene that is defective in patients with cystic fibrosis, a wealth of information about gene structure, the mutational basis of disease, and the function of the protein product has been derived. The product of the gene is a chloride channel that is regulated by adenosine 3',5'-monophosphate (cyclic AMP)-dependent protein kinase phosphorylation and that requires binding of adenosine triphosphate (ATP) for channel opening. Several new approaches to drug therapy for cystic fibrosis are now emerging, and the possibility of successful gene therapy by transfer of the normal gene to airway epithelial cells is being vigorously pursued.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Biofilms and type III secretion are not mutually exclusive in Pseudomonas aeruginosa.
H. Mikkelsen, N. J. Bond, M. E. Skindersoe, M. Givskov, K. S. Lilley, and M. Welch (2009)
Microbiology 155, 687-698
   Abstract »    Full Text »    PDF »
Phosphodiesterase 5 Inhibitors and Cystic Fibrosis: Correcting Chloride Channel Dysfunction.
L. L. Clarke (2008)
Am. J. Respir. Crit. Care Med. 177, 469-470
   Full Text »    PDF »
Cystic Fibrosis Transmembrane Conductance Regulator Activation Is Reduced in the Small Intestine of Na+/H+ Exchanger 3 Regulatory Factor 1 (NHERF-1)- but Not NHERF-2-deficient Mice.
N. Broere, J. Hillesheim, B. Tuo, H. Jorna, A. B. Houtsmuller, S. Shenolikar, E. J. Weinman, M. Donowitz, U. Seidler, H. R. de Jonge, et al. (2007)
J. Biol. Chem. 282, 37575-37584
   Abstract »    Full Text »    PDF »
Omega-3 polyunsaturated fatty acids improve host response in chronic Pseudomonas aeruginosa lung infection in mice.
M. Pierre, M.-O. Husson, R. L. Berre, J.-L. Desseyn, C. Galabert, L. Beghin, C. Beermann, A. Dagenais, Y. Berthiaume, B. Cardinaud, et al. (2007)
Am J Physiol Lung Cell Mol Physiol 292, L1422-L1431
   Abstract »    Full Text »    PDF »
NHE-RF1 protein rescues {Delta}F508-CFTR function.
F. Bossard, A. Robay, G. Toumaniantz, S. Dahimene, F. Becq, J. Merot, and C. Gauthier (2007)
Am J Physiol Lung Cell Mol Physiol 292, L1085-L1094
   Abstract »    Full Text »    PDF »
Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis..
N N Sanders, H Franckx, K De Boeck, J Haustraete, S C De Smedt, and J Demeester (2006)
Thorax 61, 962-966
   Abstract »    Full Text »    PDF »
Cystic Fibrosis, Disease Severity, and a Macrophage Migration Inhibitory Factor Polymorphism.
B. J. Plant, C. G. Gallagher, R. Bucala, J. A. Baugh, S. Chappell, L. Morgan, C. M. O'Connor, K. Morgan, and S. C. Donnelly (2005)
Am. J. Respir. Crit. Care Med. 172, 1412-1415
   Abstract »    Full Text »    PDF »
Expression of the psl Operon in Pseudomonas aeruginosa PAO1 Biofilms: PslA Performs an Essential Function in Biofilm Formation.
J. Overhage, M. Schemionek, J. S. Webb, and B. H. A. Rehm (2005)
Appl. Envir. Microbiol. 71, 4407-4413
   Abstract »    Full Text »    PDF »
Most F508del-CFTR Is Targeted to Degradation at an Early Folding Checkpoint and Independently of Calnexin.
C. M. Farinha and M. D. Amaral (2005)
Mol. Cell. Biol. 25, 5242-5252
   Abstract »    Full Text »    PDF »
Transfected {beta}3- but Not {beta}2-Adrenergic Receptors Regulate Cystic Fibrosis Transmembrane Conductance Regulator Activity via a New Pathway Involving the Mitogen-Activated Protein Kinases Extracellular Signal-Regulated Kinases.
A. Robay, G. Toumaniantz, V. Leblais, and C. Gauthier (2005)
Mol. Pharmacol. 67, 648-654
   Abstract »    Full Text »    PDF »
Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: Potential therapy for cystic fibrosis.
G. Wang, B. A. Bunnell, R. G. Painter, B. C. Quiniones, S. Tom, N. A. Lanson Jr, J. L. Spees, D. Bertucci, A. Peister, D. J. Weiss, et al. (2005)
PNAS 102, 186-191
   Abstract »    Full Text »    PDF »
Gene therapy in clinical medicine.
S M Selkirk (2004)
Postgrad. Med. J. 80, 560-570
   Abstract »    Full Text »    PDF »
A domain mimic increases {Delta}F508 CFTR trafficking and restores cAMP-stimulated anion secretion in cystic fibrosis epithelia.
L. L. Clarke, L. R. Gawenis, T.-C. Hwang, N. M. Walker, D. B. Gruis, and E. M. Price (2004)
Am J Physiol Cell Physiol 287, C192-C199
   Abstract »    Full Text »    PDF »
Abnormal Paneth cell granule dissolution and compromised resistance to bacterial colonization in the intestine of CF mice.
L. L. Clarke, L. R. Gawenis, E. M. Bradford, L. M. Judd, K. T. Boyle, J. E. Simpson, G. E. Shull, H. Tanabe, A. J. Ouellette, C. L. Franklin, et al. (2004)
Am J Physiol Gastrointest Liver Physiol 286, G1050-G1058
   Abstract »    Full Text »    PDF »
Detection of Five Common CFTR Mutations by Rapid-Cycle Real-Time Amplification Refractory Mutation System PCR.
E. Dempsey, D. E. Barton, and F. Ryan (2004)
Clin. Chem. 50, 773-775
   Full Text »    PDF »
CFTR Localization in Native Airway Cells and Cell Lines Expressing Wild-type or F508del-CFTR by a Panel of Different Antibodies.
I. Carvalho-Oliveira, A. Efthymiadou, R. Malho, P. Nogueira, M. Tzetis, E. Kanavakis, M. D. Amaral, and D. Penque (2004)
J. Histochem. Cytochem. 52, 193-203
   Abstract »    Full Text »    PDF »
A Phase I Trial of Intranasal Moli1901 for Cystic Fibrosis.
P. L. Zeitlin, M. P. Boyle, W. B. Guggino, and L. Molina (2004)
Chest 125, 143-149
   Abstract »    Full Text »    PDF »
Mutations in the Nucleotide Binding Domain 1 Signature Motif Region Rescue Processing and Functional Defects of Cystic Fibrosis Transmembrane Conductance Regulator Delta F508.
A. C. V. deCarvalho, L. J. Gansheroff, and J. L. Teem (2002)
J. Biol. Chem. 277, 35896-35905
   Abstract »    Full Text »    PDF »
Cystic Fibrosis Transmembrane Regulator Gene (CFTR) is Associated with Abnormal Enamel Formation.
C.K. Arquitt, C. Boyd, and J.T. Wright (2002)
Journal of Dental Research 81, 492-496
   Abstract »    Full Text »    PDF »
Long-term Benefits of Inhaled Tobramycin in Adolescent Patients With Cystic Fibrosis.
R. B. Moss (2002)
Chest 121, 55-63
   Abstract »    Full Text »    PDF »
Cystic fibrosis patients with the 3272-26A>G splicing mutation have milder disease than F508del homozygotes: a large European study.
M. D Amaral, P. Pacheco, S. Beck, C. M Farinha, D. Penque, P. Nogueira, C. Barreto, B. Lopes, T. Casals, J. Dapena, et al. (2001)
J. Med. Genet. 38, 777-783
   Full Text »    PDF »
Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF.
J. Navarro, M. Rainisio, H.K. Harms, M.E. Hodson, C. Koch, G. Mastella, B. Strandvik, and S.G. McKenzie (2001)
Eur. Respir. J. 18, 298-305
   Abstract »    Full Text »    PDF »
Management of Pulmonary Disease in Patients with Cystic Fibrosis.
C. A. Robinson and R. J. Kuhn (2001)
Journal of Pharmacy Practice 14, 207-227
   Abstract »    PDF »
New Models of the Tracheal Airway Define the Glandular Contribution to Airway Surface Fluid and Electrolyte Composition.
X. Wang, Y. Zhang, A. Amberson, and J. F. Engelhardt (2001)
Am. J. Respir. Cell Mol. Biol. 24, 195-202
   Abstract »    Full Text »
Inflammation and infection in cystic fibrosis - hen or egg?.
N. Hoiby (2001)
Eur. Respir. J. 17, 4-5
   Full Text »    PDF »
Microbial Biofilms: from Ecology to Molecular Genetics.
M. E. Davey and G. A. O'toole (2000)
Microbiol. Mol. Biol. Rev. 64, 847-867
   Abstract »    Full Text »    PDF »
G1 Phase Growth Arrest and Induction of p21Waf1/Cip1/Sdi1 in IB3-1 Cells Treated with 4-Sodium Phenylbutyrate.
S. A. McGrath-Morrow and J. L. Stahl (2000)
J. Pharmacol. Exp. Ther. 294, 941-947
   Abstract »    Full Text »
Cystic Fibrosis : End-Stage Care in Canada.
I. Mitchell, E. Nakielna, E. Tullis, and C. Adair (2000)
Chest 118, 80-84
   Abstract »    Full Text »    PDF »
Innate Lung Defenses and Compromised Pseudomonas aeruginosa Clearance in the Malnourished Mouse Model of Respiratory Infections in Cystic Fibrosis.
H. Yu, S. Z. Nasr, and V. Deretic (2000)
Infect. Immun. 68, 2142-2147
   Abstract »    Full Text »    PDF »
cAMP-dependent Cl- Channel Protein (CFTR) and Its mRNA Are Expressed in the Secretory Portion of Human Eccrine Sweat Gland.
F. Sato and K. Sato (2000)
J. Histochem. Cytochem. 48, 345-354
   Abstract »    Full Text »
Effects of Methacholine and Uridine 5'-Triphosphate on Tracheal Mucus Rheology in Mice.
E. Sudo, M. M. Lee, W. A. Boyd, and M. King (2000)
Am. J. Respir. Cell Mol. Biol. 22, 373-379
   Abstract »    Full Text »
Shaping a Positive Future for Academic Medicine at Michigan.
G. S. Omenn, A. S. Lichter, L. Warren, and L. C. Bollinger (2000)
JAMA 283, 927-928
   Full Text »    PDF »
Increasing Epithelial Junction Permeability Enhances Gene Transfer to Airway Epithelia In Vivo.
G. Wang, J. Zabner, C. Deering, J. Launspach, J. Shao, M. Bodner, D. J. Jolly, B. L. Davidson, and P. B. McCray Jr. (2000)
Am. J. Respir. Cell Mol. Biol. 22, 129-138
   Abstract »    Full Text »
Correction of Aberrant Splicing of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene by Antisense Oligonucleotides.
K. J. Friedman, J. Kole, J. A. Cohn, M. R. Knowles, L. M. Silverman, and R. Kole (1999)
J. Biol. Chem. 274, 36193-36199
   Abstract »    Full Text »    PDF »
A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr-/- mice.
S. D. Freedman, M. H. Katz, E. M. Parker, M. Laposata, M. Y. Urman, and J. G. Alvarez (1999)
PNAS 96, 13995-14000
   Abstract »    Full Text »    PDF »
Channelopathies of inwardly rectifying potassium channels.
M. R. ABRAHAM, A. JAHANGIR, A. E. ALEKSEEV, and A. TERZIC (1999)
FASEB J 13, 1901-1910
   Abstract »    Full Text »
Association of Cystic Fibrosis Transmembrane Conductance Regulator and Protein Phosphatase 2C.
T. Zhu, D. Dahan, A. Evagelidis, S.-X. Zheng, J. Luo, and J. W. Hanrahan (1999)
J. Biol. Chem. 274, 29102-29107
   Abstract »    Full Text »    PDF »
A Six-Month Study of Growth and Energy Expenditure in Children with Cystic Fibrosis Taking a Pulmonary Inhalation Medication (rhDNase).
E. B. Fung, E. M. Barden, D. Wasserman, B. S. Zemel, B. T. Heinrich, T. F. Scanlin, and V. A. Stallings (1999)
J. Am. Coll. Nutr. 18, 330-338
   Abstract »    Full Text »    PDF »
Nucleotide Occlusion in the Human Cystic Fibrosis Transmembrane Conductance Regulator. DIFFERENT PATTERNS IN THE TWO NUCLEOTIDE BINDING DOMAINS.
K. Szabo, G. Szakacs, T. Hegedus, and B. Sarkadi (1999)
J. Biol. Chem. 274, 12209-12212
   Abstract »    Full Text »    PDF »
Desensitization of P2Y2 receptor-activated transepithelial anion secretion.
L. L. Clarke, M. C. Harline, M. A. Otero, G. G. Glover, R. C. Garrad, B. Krugh, N. M. Walker, F. A. Gonzalez, J. T. Turner, and G. A. Weisman (1999)
Am J Physiol Cell Physiol 276, C777-C787
   Abstract »    Full Text »    PDF »
Liver Disease in Children with Cystic Fibrosis: US-Biochemical Comparison in 195 Patients.
H. Patriquin, C. Lenaerts, L. Smith, G. Perreault, A. Grignon, D. Filiatrault, J. Boisvert, C. C. Roy, and A. Rasquin-Weber (1999)
Radiology 211, 229-232
   Abstract »    Full Text »
Processing of CFTR bearing the P574H mutation differs from wild-type and deltaF508-CFTR.
L. Ostedgaard, B Zeiher, and M. Welsh (1999)
J. Cell Sci. 112, 2091-2098
   Abstract »    PDF »
Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes.
L. Zhang, D. Wang, H. Fischer, P.-d. Fan, J. H. Widdicombe, Y. W. Kan, and J.-y. Dong (1998)
PNAS 95, 10158-10163
   Abstract »    Full Text »    PDF »
Improved Potency of Hyperactive and Actin-resistant Human DNase I Variants for Treatment of Cystic Fibrosis and Systemic Lupus Erythematosus.
C. Q. Pan, T. H. Dodge, D. L. Baker, W. S. Prince, D. V. Sinicropi, and R. A. Lazarus (1998)
J. Biol. Chem. 273, 18374-18381
   Abstract »    Full Text »    PDF »
Pseudomonas aeruginosa Infection as a Complication of Therapy in Pancreatic Fibrosis (Mucoviscidosis), by Sterling D. Garrard, et al, Pediatrics, 1951;8:482.
B. W. Ramsey (1998)
Pediatrics 102, 210-213
   Abstract »    Full Text »
Genetics and pulmonary medicine bullet  1: The genetics of cystic fibrosis lung disease.
D. J Davidson and D. J Porteous (1998)
Thorax 53, 389-397
   Full Text »
Research on Cystic Fibrosis . A Journey from the Heart House.
M. J. WELSH and B. W. RAMSEY (1998)
Am. J. Respir. Crit. Care Med. 157, S148-S154
   Full Text »    PDF »
The Emerging Technology and Application of Preimplantation Genetic Diagnosis.
R. J. Tasca and M. E. McClure (1998)
J. Law Med. Ethics 26, 7-16
   PDF »
Improved Clearability of Cystic Fibrosis Sputum with Dextran Treatment in vitro.
W. FENG, H. GARRETT, D. P. SPEERT, and M. KING (1998)
Am. J. Respir. Crit. Care Med. 157, 710-714
   Abstract »    Full Text »    PDF »
Microbial Pathogenesis in Cystic Fibrosis: Pulmonary Clearance of Mucoid Pseudomonas aeruginosa and Inflammation in a Mouse Model of Repeated Respiratory Challenge.
H. Yu, M. Hanes, C. E. Chrisp, J. C. Boucher, and V. Deretic (1998)
Infect. Immun. 66, 280-288
   Abstract »    Full Text »    PDF »
RhDNase I Aerosol Deposition and Related Factors in Cystic Fibrosis.
P. DIOT, L. B. PALMER, A. SMALDONE, J. DECELIE-GERMANA, R. GRIMSON, and G. C. SMALDONE (1997)
Am. J. Respir. Crit. Care Med. 156, 1662-1668
   Abstract »    Full Text »
Genetics of Asthma . Conference Summary.
J. M. DRAZEN and E. K. SILVERMAN (1997)
Am. J. Respir. Crit. Care Med. 156, S69-S71
   Full Text »    PDF »
Block by MOPS reveals a conformation change in the CFTR pore produced by ATP hydrolysis.
H. Ishihara and M. J. Welsh (1997)
Am J Physiol Cell Physiol 273, C1278-C1289
   Abstract »    Full Text »    PDF »
Protein phosphatase 2C dephosphorylates and inactivates cystic fibrosis transmembrane conductance regulator.
S. M. Travis, H. A. Berger, and M. J. Welsh (1997)
PNAS 94, 11055-11060
   Abstract »    Full Text »    PDF »
End-of-Life Care in Cystic Fibrosis.
W. M. Robinson, S. Ravilly, C. Berde, and M. E. Wohl (1997)
Pediatrics 100, 205-209
   Abstract »    Full Text »    PDF »
Rheology of Cystic Fibrosis Sputum after in vitro Treatment with Hypertonic Saline Alone and in Combination with Recombinant Human Deoxyribonuclease I.
M. KING, B. DASGUPTA, R. P. TOMKIEWICZ, and N. E. BROWN (1997)
Am. J. Respir. Crit. Care Med. 156, 173-177
   Abstract »    Full Text »
Cystic Fibrosis Transmembrane Conductance Regulator Inverts Protein Kinase A-mediated Regulation of Epithelial Sodium Channel Single Channel Kinetics.
M. J. Stutts, B. C. Rossier, and R. C. Boucher (1997)
J. Biol. Chem. 272, 14037-14040
   Abstract »    Full Text »    PDF »
Ion Channels -- Basic Science and Clinical Disease.
M. J. Ackerman and D. E. Clapham (1997)
N. Engl. J. Med. 336, 1575-1586
   Full Text »    PDF »
Benefits and Burdens of Genetic Carrier Identification.
J. K. Williams and D. L. Schutte (1997)
West J Nurs Res 19, 71-81
   Abstract »    PDF »
Enamel Mineral Composition of Normal and Cystic Fibrosis Transgenic Mice.
J.T. Wright, K.I. Hall, and B.R. Grubb (1996)
Advances in Dental Research 10, 270-275
   Abstract »    PDF »
Management of Pulmonary Disease in Patients with Cystic Fibrosis.
B. W. Ramsey (1996)
N. Engl. J. Med. 335, 179-188
   Full Text »    PDF »
Abnormal Enamel Development in a Cystic Fibrosis Transgenic Mouse Model.
J.T. Wright, C.L. Kiefer, K.I. Hall, and B.R. Grubb (1996)
Journal of Dental Research 75, 966-973
   Abstract »    PDF »
Regulation of Epithelial Sodium Channels by the Cystic Fibrosis Transmembrane Conductance Regulator.
I. I. Ismailov, M. S. Awayda, B. Jovov, B. K. Berdiev, C. M. Fuller, J. R. Dedman, M. A. Kaetzel, and D. J. Benos (1996)
J. Biol. Chem. 271, 4725-4732
   Abstract »    Full Text »    PDF »
Management of the Child With Cystic Fibrosis.
J. H. Tran and K. M. Brennan (1996)
Journal of Pharmacy Practice 9, 75-90
   Abstract »    PDF »
Isotype-specific Activation of Cystic Fibrosis Transmembrane Conductance Regulator-Chloride Channels by cGMP-dependent Protein Kinase II.
P. J. French, J. Bijman, M. Edixhoven, A. B. Vaandrager, B. J. Scholte, S. M. Lohmann, A. C. Nairn, and H. R. de Jonge (1995)
J. Biol. Chem. 270, 26626-26631
   Abstract »    Full Text »    PDF »
Transfer of Genes to Humans: Early Lessons and Obstacles to Success.
R. G. Crystal (1995)
Science 270, 404-410
   Abstract »    PDF »
A Controlled Study of Adenoviral-Vector-Mediated Gene Transfer in the Nasal Epithelium of Patients with Cystic Fibrosis.
M. R. Knowles, K. W. Hohneker, Z. Zhou, J. C. Olsen, T. L. Noah, P.-C. Hu, M. W. Leigh, J. F. Engelhardt, L. J. Edwards, K. R. Jones, et al. (1995)
N. Engl. J. Med. 333, 823-831
   Abstract »    Full Text »    PDF »
Alternate Translation Initiation Codons Can Create Functional Forms of Cystic Fibrosis Transmembrane Conductance Regulator.
T. P. Carroll, M. M. Morales, S. B. Fulmer, S. S. Allen, T. R. Flotte, G. R. Cutting, and W. B. Guggino (1995)
J. Biol. Chem. 270, 11941-11946
   Abstract »    Full Text »    PDF »
Management of Sinusitis in Cystic Fibrosis by Endoscopic Surgery and Serial Antimicrobial Lavage: Reduction in Recurrence Requiring Surgery.
R. B. Moss and V. V. King (1995)
Arch Otolaryngol Head Neck Surg 121, 566-572
   Abstract »    PDF »
cis-Acting Elements Involved in the Regulation of Mouse Clara Cell-specific 10-kDa Protein Gene.
M. K. Ray, S. W. Magdaleno, M. J. Finegold, and F. J. DeMayo (1995)
J. Biol. Chem. 270, 2689-2694
   Abstract »    Full Text »    PDF »
Sequence Comparison of Yeast ATP-binding Cassette Proteins.
S. Michealis and C. Berkower (1995)
Cold Spring Harb Symp Quant Biol 60, 291-307
   Abstract »    PDF »
A Novel Mutation in the Cystic Fibrosis Gene in Patients with Pulmonary Disease but Normal Sweat Chloride Concentrations.
W. E. Highsmith, L. H. Burch, Z. Zhou, J. C. Olsen, T. E. Boat, A. Spock, J. D. Gorvoy, L. Quittell, K. J. Friedman, L. M. Silverman, et al. (1994)
N. Engl. J. Med. 331, 974-980
   Abstract »    Full Text »
Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis.
H. J. Fuchs, D. S. Borowitz, D. H. Christiansen, E. M. Morris, M. L. Nash, B. W. Ramsey, B. J. Rosenstein, A. L. Smith, M. E. Wohl, and The Pulmozyme Study Group (1994)
N. Engl. J. Med. 331, 637-642
   Abstract »    Full Text »
Progress Toward Human Gene Therapy.
M. A. Morsy, K. Mitani, P. Clemens, and C. T. Caskey (1993)
JAMA 270, 2338-2345
   Abstract »    PDF »
Clinical Physiology of Heritable Photoreceptor Diseases.
A. B. Fulton and M. E. Breton (1993)
Arch Ophthalmol 111, 1479-1481
   Abstract »    PDF »
Sickle Cell Anemia: {beta}s Gene Cluster Haplotypes as Genetic Markers for Severe Disease Expression.
D. Powars and A. Hiti (1993)
Arch Pediatr Adolesc Med 147, 1197-1202
   Abstract »    PDF »
Recent Advances in Pulmonary Medicine- First of Two Parts.
S. E. Weinberger (1993)
N. Engl. J. Med. 328, 1389-1397
   Full Text »
SV2, a brain synaptic vesicle protein homologous to bacterial transporters.
S. Bajjalieh, K Peterson, R Shinghal, and R. Scheller (1992)
Science 257, 1271-1273
   Abstract »    PDF »
An Animal Model for Cystic Fibrosis Made by Gene Targeting.
J. N. Snouwaert, K. K. Brigman, A. M. Latour, N. N. Malouf, R. C. Boucher, O. Smithies, and B. H. Koller (1992)
Science 257, 1083-1088
   Abstract »    PDF »
Enhanced Activity of a Large Conductance, Calcium-sensitive K+ Channel in the Presence of Src Tyrosine Kinase.
S. Ling, G. Woronuk, L. Sy, S. Lev, and A. P. Braun (2000)
J. Biol. Chem. 275, 30683-30689
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)